000 | 01387 a2200385 4500 | ||
---|---|---|---|
005 | 20250513090549.0 | ||
264 | 0 | _c19960626 | |
008 | 199606s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElder, D J | |
245 | 0 | 0 |
_aDifferential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. _h[electronic resource] |
260 |
_bCancer research _cMay 1996 |
||
300 |
_a2273-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a3T3 Cells |
650 | 0 | 4 |
_aAdenoma _xpathology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacokinetics |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aAspirin _xpharmacokinetics |
650 | 0 | 4 |
_aCarcinoma _xpathology |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 | _aCell Line, Transformed |
650 | 0 | 4 |
_aColorectal Neoplasms _xpathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aSodium Salicylate _xpharmacology |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
700 | 1 | _aHague, A | |
700 | 1 | _aHicks, D J | |
700 | 1 | _aParaskeva, C | |
773 | 0 |
_tCancer research _gvol. 56 _gno. 10 _gp. 2273-6 |
|
999 |
_c8624342 _d8624342 |